Associated Papers
Genetic susceptibility to febrile seizures: case-control association studies.
Kira R et al.
Brain & Development, 2010
A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
Ohnishi T et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 2007
Genetic variants in the IMPA2 gene do not confer increased risk of febrile seizures in Caucasian patients.
Blair MA et al.
European Journal of Neurology, 2007
Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
Dimitrova A et al.
The Pharmacogenomics Journal, 2005
Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.
Nakayama J et al.
Neurology, 2004
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
Sjøholt G et al.
Molecular Psychiatry, 2004
A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.
Sjøholt G et al.
Molecular Psychiatry, 2000
Select a paper to view details